News

Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas
START and Allegheny Health Network to expand access to early-phase cancer trials
read more
Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas
Polaryx advances Phase 2 trial of PLX-200 in four rare diseases
read more
Advanced Therapies,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development
Lumen Bioscience gets up to $7M to advance LMN-1001 into Phase 1
read more
Advanced Therapies,Clinical & Regulatory,Digital & Data,Research & Development,Therapeutic Areas
Brainomix to present five ILD studies on quantitative CT at ERS Congress
read more
Advanced Therapies,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development
Genespire starts international MMA study to support GENE202 development
read more
Digital & Data,Drug Discovery & Development,Research & Development
Insilico launches open consortium to assess AI drug discovery benchmarks
read more
Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas
FDA grants Fast Track designation to Erasca pancreatic cancer drug
read more
Drug Discovery & Development,Research & Development
Anthropic AI protein designs undergo large-scale experimental validation
read more
Clinical & Regulatory,Medical devices,Pharmaceuticals and therapeutics,Therapeutic Areas
FDA grants De Novo authorisation to Avulux migraine light-sensitivity lens
read more
Clinical & Regulatory,Digital & Data,Medical devices,Research & Development,Therapeutic Areas
Oxford research to explore AI stroke prediction from routine cardiac CT at ESC 2026
read more
Clinical & Regulatory,Medical devices,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas
Robotic gastrectomy shows benefits over laparoscopic surgery in gastric cancer
read more
Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development
Leicester clinic offers Galleri blood test following NHS cancer trial
read more
Drug Delivery & Formulation,Manufacturing & Supply Chain,Research & Development
Lonza launches rapid custom media service for early bioprocess development
read more
Manufacturing & Supply Chain
TraceLink MINT transaction volume surges 183% in 2026
read more
Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development
Poolbeg Pharma trial targets cytokine release syndrome in multiple myeloma
read more
Drug Discovery & Development,Pharmaceuticals and therapeutics
FairJourney Bio builds switch to activate IL-12 in tumours
read more

START and Allegheny Health Network to expand access to early-phase cancer trials

Polaryx advances Phase 2 trial of PLX-200 in four rare diseases

Lumen Bioscience gets up to $7M to advance LMN-1001 into Phase 1

Brainomix to present five ILD studies on quantitative CT at ERS Congress

Genespire starts international MMA study to support GENE202 development

Insilico launches open consortium to assess AI drug discovery benchmarks

FDA grants Fast Track designation to Erasca pancreatic cancer drug

Anthropic AI protein designs undergo large-scale experimental validation

FDA grants De Novo authorisation to Avulux migraine light-sensitivity lens

Oxford research to explore AI stroke prediction from routine cardiac CT at ESC 2026

Robotic gastrectomy shows benefits over laparoscopic surgery in gastric cancer

Leicester clinic offers Galleri blood test following NHS cancer trial

Lonza launches rapid custom media service for early bioprocess development

TraceLink MINT transaction volume surges 183% in 2026

Poolbeg Pharma trial targets cytokine release syndrome in multiple myeloma

FairJourney Bio builds switch to activate IL-12 in tumours

main menu

recent posts

How AI is reshaping clinical trials: Saama on the next phase of regulated AI

MRI study suggests some prostate cancer biopsies could eventually be avoided

START and Allegheny Health Network to expand access to early-phase cancer trials

get connected